abstract |
An object of the present invention is to provide a therapeutic agent for ulcerative colitis. (1S, 3S) -1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid, (1R, 3S) -1-methyl-1,2,3,4 -The therapeutic agent for ulcerative colitis was obtained by including either one or both of tetrahydro-β-carboline-3-carboxylic acid. [Selection figure] None |